Michael Colrus - Scibase AB Chief Officer
| SCIB Stock | SEK 0.42 0.03 7.69% |
Insider
Michael Colrus is Chief Officer of Scibase AB
| Age | 61 |
| Phone | 46 8 41 06 20 00 |
| Web | https://www.scibase.com |
Scibase AB Management Efficiency
The company has return on total asset (ROA) of (0.4288) % which means that it has lost $0.4288 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.8992) %, meaning that it generated substantial loss on money invested by shareholders. Scibase AB's management efficiency ratios could be used to measure how well Scibase AB manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Peter Madsen | Cantargia AB | N/A | |
| Pal Ryfors | Episurf Medical AB | 40 | |
| Stephen Caswell | Episurf Medical AB | 42 | |
| Johanna Christensen | Cantargia AB | N/A | |
| Veronica Wallin | Episurf Medical AB | 37 | |
| Thomas Lundstrm | Acarix AS | 49 | |
| Fredrik Zetterberg | Episurf Medical AB | 48 | |
| Associate Gier | Xbrane Biopharma AB | N/A | |
| Maria Edebrink | Xbrane Biopharma AB | 54 | |
| Beata Lihammar | Episurf Medical AB | N/A | |
| Katarina Flodstrm | Episurf Medical AB | 48 | |
| Anette Lindqvist | Xbrane Biopharma AB | 57 | |
| Marianne Norskov | Acarix AS | 45 | |
| Thoas MD | Cantargia AB | 61 | |
| Marcuss | Cantargia AB | N/A | |
| Dominique Tersago | Cantargia AB | 61 | |
| Susanne Lagerlund | Cantargia AB | N/A | |
| Tobias Fritz | Acarix AS | 44 | |
| Martin mark | Xbrane Biopharma AB | 43 | |
| Michael Nsstrm | Episurf Medical AB | 34 | |
| Helen Round | Acarix AS | 59 | |
Management Performance
| Return On Equity | -0.9 | |||
| Return On Asset | -0.43 |
Scibase AB Leadership Team
Elected by the shareholders, the Scibase AB's board of directors comprises two types of representatives: Scibase AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Scibase. The board's role is to monitor Scibase AB's management team and ensure that shareholders' interests are well served. Scibase AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Scibase AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Stig Ollmar, Founder, Chief Scientific Officer, Director, Inventor | ||
| Tobias Bergenblad, Global Sales Manager | ||
| Simon Grant, CEO Pres | ||
| Per Svedenhag, Head of Business Development and Marketing | ||
| Michael Colrus, Chief Officer | ||
| Linn Olsen, Head Production |
Scibase Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Scibase AB a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.9 | |||
| Return On Asset | -0.43 | |||
| Profit Margin | (2.41) % | |||
| Operating Margin | (2.59) % | |||
| Current Valuation | 208.42 M | |||
| Shares Outstanding | 68.48 M | |||
| Shares Owned By Insiders | 26.42 % | |||
| Shares Owned By Institutions | 16.44 % | |||
| Price To Earning | (2.75) X | |||
| Price To Book | 7.00 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Scibase Stock Analysis
When running Scibase AB's price analysis, check to measure Scibase AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scibase AB is operating at the current time. Most of Scibase AB's value examination focuses on studying past and present price action to predict the probability of Scibase AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scibase AB's price. Additionally, you may evaluate how the addition of Scibase AB to your portfolios can decrease your overall portfolio volatility.